S. Dadiboyena et al. / Tetrahedron Letters 51 (2010) 1341–1343
1343
Acknowledgments
We thank the National Institutes of Health MBRS-SCORE and
RCMI programs (3S06 GM 008047-34S1 and G12RR13459 (NMR
and Analytical CORE facilities)) and the National Science Founda-
tion NSF-RISE program (HRD-0734645). E.J.V. gratefully acknowl-
edges the support of the National Science Foundation grant MRI
0618148 and the W. M. Keck Foundation for crystallographic
resources.
References and notes
1. Shen, D.; Shu, M.; Chapman, K. T. Org. Lett. 2000, 2, 2789.
2. Penning, T. D.; Talley, J. J.; Bertenshaw, S. R.; Carter, J. S.; Collins, P. W.; Docter,
S.; Graneto, M. J.; Lee, L. F.; Malecha, J. W.; Miyashiro, J. M.; Rogers, R. S.; Rogier,
D. J.; Yu, S. S.; Anderson, G. D.; Burton, E. G.; Cogburn, J. N.; Gregory, S. A.;
Koboldt, C. M.; Perkins, W. E.; Seibert, K.; Veenhuizen, A. W.; Zhang, Y. Y.;
Isakson, P. C. J. Med. Chem. 1997, 40, 1347.
3. Deng, X.; Mani, N. S. Org. Lett. 2008, 10, 1307.
4. (a) Katritzky, A. R.; Wang, M.; Zhang, S.; Voronkov, M. V. J. Org. Chem. 2001, 66,
6787; (b) Elguero, J.. In Comprehensive Heterocyclic Chemistry II; Katritzky, A. R.,
Rees, C. W., Scriven, E. F. V., Eds.; Pergamon: Oxford, 1996; Vol. 3, p 1.
5. Deng, X.; Mani, N. S. Org. Lett. 2006, 8, 3505.
6. Donohue, A. C.; Pallich, S.; McCarthy, T. D. J. Chem. Soc., Perkin Trans. 1 2001,
2817.
7. (a) Chiericato, M.; Croce, P. D.; Carganico, G.; Maiorana, S. J. Heterocycl. Chem.
1979, 16, 383; (b) Abunada, N. M.; Hassaneen, H. M.; Kandile, N. G.; Miqdad, O.
A. Molecules 2008, 13, 1501.
8. (a) Huisgen, R. Angew. Chem., Int. Ed. Engl. 1963, 2, 565; (b) Huisgen, R. Angew.
Chem., Int. Ed. Engl. 1963, 2, 633; (c) Browne, D. L.; Vivat, J. F.; Plant, A.; Gomez-
Bengoa, E.; Harrity, J. P. A. J. Am. Chem. Soc. 2009, 131, 7762.
9. (a) Oh, L. Tetrahedron Lett. 2006, 47, 7943; (b) de Lucchi, O.; Modena, G.
Tetrahedron 1984, 40, 2585; (c) Lu, J.-Y.; Keith, J. A.; Shen, W.-Z.; Schurmann,
M.; Preut, H.; Jacob, T.; Arndt, H.-D. J. Am. Chem. Soc. 2008, 130, 13219; (d)
Aggarwal, V. K.; de Vicente, J.; Bonnert, R. V. J. Org. Chem. 2003, 68, 5381; (e)
Chandrasekhar, S.; Rajaiah, G.; Srihari, P. Tetrahedron Lett. 2001, 42, 6599.
10. (a) Easton, C. J.; Hughes, C. M.; Tiekink, E. R. T.; Lubin, C. E.; Savage, G. P.;
Simpson, G. W. Tetrahedron Lett. 1994, 35, 3589; (b) Easton, C. J.; Heath, G. A.;
Hughes, C. M. M.; Lee, C. K. Y.; Savage, G. P.; Simpson, G. W.; Tiekink, E. R. T.;
Vuckovic, G. J.; Webster, R. D. J. Chem. Soc., Perkin Trans. 1 2001, 1168; (c)
Jimenez, R.; Perez, L.; Tamariz, J.; Salgado, H. Heterocycles 1993, 35, 591.
11. (a) Dadiboyena, S.; Xu, J.; Hamme, A. T., II Tetrahedron Lett. 2007, 48, 1295; (b)
Xu, J.; Hamme, A. T., II Synlett 2008, 919; (c) Hamme, A. T., II; Xu, J.; Wang, J.;
Cook, T.; Ellis, E. Heterocycles 2005, 65, 2885.
Figure 2. Thermal ellipsoid plot of 4 drawn at the 50% probability level.13
room temperature, and no decomposition to the corresponding al-
kyne was observed. The study of the 1,3-dipolar cycloaddition reac-
tion of compound 1 with other nitrile imines was undertaken in
order to determine the general efficacy of a-bromocinnamaldehyde
as an alkyne equivalent. All these cycloadditions occurred with
complete regiochemical integrity in reasonable to good isolated
yields. The results of the cycloaddition of 1 with five different nitrile
imines with various functionalities are shown in Table 1.
The existence of pyrazole (4) as a crystalline solid enabled us to
perform X-ray studies to reveal compound’s regio-structural fea-
tures. Compound 4 was unambiguously confirmed by X-ray struc-
tural analysis as a 1,3,4,5-tetrasubstituted pyrazole where the
benzene rings are located at the 3 and 4 positions of the pyrazole.
(Fig. 2) This X-ray analysis provided evidence that the Huisgen
cyclization occurred through intermediate 3 as shown in Scheme
1. The structures of the remaining pyrazoles were elucidated based
upon their NMR spectroscopic data.
12. Dawood, K. M.; Fuchigami, T. J. Org. Chem. 2005, 70, 7537.
13. Structural information for pyrazole (4) has been deposited with the CCDC as
Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033).
2. Conclusion
In summary, we report a facile and regioselective synthesis of
1,3,4,5-tetrasubstituted pyrazoles through the 1,3-dipolar cycload-
dition of nitrile imines with a-bromocinnamaldehyde (1) as an al-
14. General experimental procedure for the 1,3-dipolar cycloaddition: A solution of a-
bromocinnamaldehyde (1) (3 mmol) and the hydrazonyl chloride (3 mmol) in
10 mL of either dry chloroform or dichloromethane was treated with
triethylamine (0.46 mL, 3.3 mmol). The reaction mixture was stirred at rt
until the disappearance of the starting materials, as evidenced by TLC. After the
reaction was complete (7–10 h), the solvent was evaporated under reduced
pressure. The crude products were purified by flash column chromatography
over silica gel by using a hexanes–ethyl acetate ratio as an eluant system. This
procedure provided pure pyrazole products for entries 1–5 in 70–86% yield.
kyne surrogate.14 The construction of the stable aromatic pyrazole
system could be the driving force behind the dehydrobromination
process. Along with the NMR data, X-ray crystallographic analysis
also confirmed the regiochemistry of the distinctive pyrazole com-
pounds. Future investigations of 1,3-dipolar cycloaddition reac-
tions with various alkyne surrogates toward the synthesis of
pyrazoles and other heterocyclic compounds are in progress.